Article

Genotype analysis identifies the cause of the "royal disease".

University of Massachusetts Medical School, 303 Belmont Street, Worcester, MA 01604, USA.
Science (Impact Factor: 31.48). 10/2009; 326(5954):817. DOI: 10.1126/science.1180660
Source: PubMed

ABSTRACT The "royal disease," a blood disorder transmitted from Queen Victoria to European royal families, is a striking example of X-linked recessive inheritance. Although the disease is widely recognized to be a form of the blood clotting disorder hemophilia, its molecular basis has never been identified, and the royal disease is now likely extinct. We identified the likely disease-causing mutation by applying genomic methodologies (multiplex target amplification and massively parallel sequencing) to historical specimens from the Romanov branch of the royal family. The mutation occurs in F9, a gene on the X chromosome that encodes blood coagulation factor IX, and is predicted to alter RNA splicing and to lead to production of a truncated form of factor IX. Thus, the royal disease is the severe form of hemophilia, also known as hemophilia B or Christmas disease.

1 Follower
 · 
269 Views
  • Human Gene Therapy 11/2014; 25(11):915-22. DOI:10.1089/hum.2014.2541 · 3.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hemorrhages occurring in the newborn without trauma have been observed by obstetricians since the 17th century, but have been considered different diseases depending on their location. Umbilical hemorrhage associated with obstructed bile canals was described by Cheyne in 1802. Grandidier in 1871 and Townsend in 1894 grouped together various forms of neonatal bleeds and associated them with disturbed coagulation. When the clotting system became better understood in the last decade of the 19th century, effective symptomatic treatment was developed: gelatin, serum injection, and the transfusion of fresh blood. In 1935, Dam detected the function of vitamin K in the coagulation system and 4 years later, Waddell introduced vitamin K administration into therapy and prevention of neonatal hemorrhagic disease. Kernicterus occurred when high doses of synthetic water-soluble vitamin K analogues were given to preterm infants, reminding physicians that progress in neonatal therapy rests on the cornerstones of controlled trials and follow-up. © 2015 S. Karger AG, Basel.
    Neonatology 01/2015; 107(3):206-212. DOI:10.1159/000369523 · 2.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To review hemophilia A with emphasis on its oral manifestations, investigations, and dental management. Search was conducted using internet-based search engines, scholarly bibliographic databases, PubMed, and Medline with key words such as "Hemophilia A," "factor VIII," "bleeding and clotting disorders," and "dental management." Hemophilia comprises a group of hereditary disorders caused due to the deficiency of one or more clotting factors leading to prolonged clotting time and excessive bleeding tendencies. It is broadly divided into hemophilia A, B, and C, which occur due to deficiency of factor VIII, IX, and XI, respectively. Hemophilia A is an X-linked recessive hereditary disorder and is the most common of the three, accounting for 80-85% of the cases. Understanding this complex entity is very important for a dentist to provide appropriate dental treatment and avoid undesirable consequences.
    12/2014; 4(Suppl 3):S147-52. DOI:10.4103/2231-0762.149022